Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, X-Ray Computed | 89 | 2021 | 2441 | 12.780 |
Why?
|
Lung Diseases, Interstitial | 27 | 2020 | 187 | 9.340 |
Why?
|
Idiopathic Pulmonary Fibrosis | 17 | 2021 | 119 | 6.480 |
Why?
|
Lung | 29 | 2020 | 1002 | 4.880 |
Why?
|
Radiography, Thoracic | 21 | 2020 | 401 | 4.290 |
Why?
|
Lung Neoplasms | 20 | 2019 | 1993 | 3.090 |
Why?
|
Alveolitis, Extrinsic Allergic | 5 | 2020 | 26 | 2.560 |
Why?
|
Lymph Nodes | 7 | 2019 | 507 | 2.400 |
Why?
|
Diagnosis, Differential | 32 | 2019 | 1560 | 2.320 |
Why?
|
Diagnostic Imaging | 11 | 2019 | 424 | 2.240 |
Why?
|
Humans | 156 | 2021 | 75301 | 2.010 |
Why?
|
Idiopathic Interstitial Pneumonias | 9 | 2019 | 30 | 1.800 |
Why?
|
Solitary Pulmonary Nodule | 5 | 2018 | 170 | 1.740 |
Why?
|
Dyspnea | 5 | 2020 | 77 | 1.730 |
Why?
|
Incidental Findings | 5 | 2018 | 96 | 1.690 |
Why?
|
Lung Diseases | 8 | 2019 | 275 | 1.680 |
Why?
|
Utilization Review | 2 | 2019 | 23 | 1.630 |
Why?
|
Radiology | 11 | 2019 | 180 | 1.550 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2018 | 13 | 1.490 |
Why?
|
Radiology Department, Hospital | 2 | 2018 | 26 | 1.450 |
Why?
|
Middle Aged | 64 | 2021 | 23980 | 1.440 |
Why?
|
Cough | 3 | 2020 | 45 | 1.430 |
Why?
|
Aortic Diseases | 3 | 2019 | 103 | 1.360 |
Why?
|
Pulmonary Fibrosis | 6 | 2020 | 115 | 1.350 |
Why?
|
Interdisciplinary Communication | 2 | 2018 | 130 | 1.340 |
Why?
|
Aorta, Thoracic | 3 | 2019 | 150 | 1.320 |
Why?
|
Diagnostic Errors | 2 | 2018 | 173 | 1.310 |
Why?
|
Aged | 48 | 2021 | 17101 | 1.300 |
Why?
|
Practice Guidelines as Topic | 10 | 2019 | 1028 | 1.270 |
Why?
|
Thoracic Injuries | 5 | 2014 | 25 | 1.260 |
Why?
|
Female | 72 | 2021 | 41483 | 1.250 |
Why?
|
Wounds, Nonpenetrating | 3 | 2014 | 58 | 1.250 |
Why?
|
Male | 70 | 2021 | 39121 | 1.240 |
Why?
|
Magnetic Resonance Imaging | 10 | 2019 | 2961 | 1.170 |
Why?
|
Scleroderma, Systemic | 3 | 2020 | 40 | 1.160 |
Why?
|
Mediastinum | 3 | 2019 | 46 | 1.080 |
Why?
|
Biopsy | 7 | 2020 | 1108 | 1.080 |
Why?
|
Mucin-5B | 3 | 2019 | 12 | 1.060 |
Why?
|
Contrast Media | 14 | 2019 | 994 | 1.060 |
Why?
|
Connective Tissue Diseases | 4 | 2018 | 63 | 0.990 |
Why?
|
Pulmonary Embolism | 3 | 2020 | 178 | 0.980 |
Why?
|
Phthalazines | 2 | 2018 | 24 | 0.980 |
Why?
|
Radiology Information Systems | 3 | 2018 | 85 | 0.970 |
Why?
|
Pleura | 3 | 2020 | 30 | 0.950 |
Why?
|
Sarcoidosis, Pulmonary | 3 | 2019 | 16 | 0.950 |
Why?
|
Coronary Artery Disease | 4 | 2019 | 314 | 0.930 |
Why?
|
Early Detection of Cancer | 3 | 2018 | 262 | 0.930 |
Why?
|
Pulmonary Artery | 4 | 2019 | 273 | 0.920 |
Why?
|
BRCA2 Protein | 2 | 2018 | 120 | 0.910 |
Why?
|
Sensitivity and Specificity | 13 | 2021 | 2046 | 0.910 |
Why?
|
Lymphatic Metastasis | 5 | 2019 | 491 | 0.890 |
Why?
|
Fluorodeoxyglucose F18 | 8 | 2018 | 114 | 0.890 |
Why?
|
Survival Analysis | 5 | 2018 | 1550 | 0.880 |
Why?
|
Radiopharmaceuticals | 8 | 2018 | 155 | 0.880 |
Why?
|
Reproducibility of Results | 11 | 2021 | 2605 | 0.870 |
Why?
|
Piperazines | 2 | 2018 | 257 | 0.860 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 222 | 0.850 |
Why?
|
Pleural Diseases | 2 | 2016 | 12 | 0.850 |
Why?
|
Coronary Angiography | 6 | 2019 | 213 | 0.840 |
Why?
|
Granuloma | 3 | 2016 | 53 | 0.840 |
Why?
|
Positron-Emission Tomography | 6 | 2016 | 250 | 0.830 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2018 | 275 | 0.810 |
Why?
|
Pneumonia, Bacterial | 2 | 2016 | 22 | 0.800 |
Why?
|
Pulmonary Alveoli | 2 | 2016 | 85 | 0.800 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 1582 | 0.800 |
Why?
|
Allied Health Personnel | 1 | 2018 | 12 | 0.790 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 223 | 0.790 |
Why?
|
Retrospective Studies | 21 | 2019 | 6435 | 0.780 |
Why?
|
Urothelium | 1 | 2018 | 60 | 0.770 |
Why?
|
Feedback | 1 | 2018 | 104 | 0.760 |
Why?
|
Technology, Radiologic | 1 | 2018 | 103 | 0.760 |
Why?
|
Gadolinium | 3 | 2014 | 90 | 0.740 |
Why?
|
Physician Incentive Plans | 1 | 2016 | 20 | 0.720 |
Why?
|
Efficiency | 1 | 2016 | 34 | 0.710 |
Why?
|
Speech Recognition Software | 1 | 2016 | 6 | 0.710 |
Why?
|
Fibrosis | 6 | 2020 | 166 | 0.700 |
Why?
|
Medical Audit | 1 | 2016 | 38 | 0.700 |
Why?
|
Peer Review | 1 | 2016 | 18 | 0.700 |
Why?
|
Tracheomalacia | 1 | 2016 | 2 | 0.690 |
Why?
|
Adult | 38 | 2021 | 24240 | 0.690 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2016 | 5 | 0.680 |
Why?
|
Medical Records | 1 | 2016 | 129 | 0.680 |
Why?
|
Bronchiolitis Obliterans | 1 | 2016 | 45 | 0.660 |
Why?
|
Prevalence | 7 | 2019 | 1114 | 0.660 |
Why?
|
Prognosis | 13 | 2020 | 3424 | 0.660 |
Why?
|
Gases | 1 | 2015 | 27 | 0.650 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2013 | 150 | 0.650 |
Why?
|
Birt-Hogg-Dube Syndrome | 2 | 2014 | 2 | 0.650 |
Why?
|
Breast Implants | 1 | 2015 | 31 | 0.650 |
Why?
|
Cohort Studies | 12 | 2019 | 2426 | 0.640 |
Why?
|
Cryptogenic Organizing Pneumonia | 2 | 2012 | 6 | 0.640 |
Why?
|
Lymphangioleiomyomatosis | 2 | 2014 | 9 | 0.640 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 355 | 0.640 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 2014 | 20 | 0.630 |
Why?
|
Tracheal Diseases | 2 | 2013 | 11 | 0.630 |
Why?
|
Calcinosis | 1 | 2016 | 240 | 0.630 |
Why?
|
Psoriasis | 4 | 2018 | 203 | 0.620 |
Why?
|
Academic Medical Centers | 2 | 2018 | 357 | 0.620 |
Why?
|
Faculty, Medical | 1 | 2016 | 153 | 0.610 |
Why?
|
Motivation | 1 | 2016 | 218 | 0.610 |
Why?
|
Lung Transplantation | 2 | 2018 | 227 | 0.610 |
Why?
|
Carcinoma | 1 | 2018 | 429 | 0.600 |
Why?
|
Lymphatic Diseases | 1 | 2014 | 38 | 0.600 |
Why?
|
Lung Diseases, Obstructive | 1 | 2014 | 21 | 0.590 |
Why?
|
Societies, Medical | 11 | 2020 | 477 | 0.590 |
Why?
|
Cysts | 2 | 2014 | 99 | 0.590 |
Why?
|
Pulmonary Valve | 2 | 2020 | 24 | 0.590 |
Why?
|
Chronic Disease | 7 | 2020 | 898 | 0.580 |
Why?
|
Testicular Neoplasms | 3 | 2019 | 103 | 0.570 |
Why?
|
Sarcoidosis | 1 | 2014 | 85 | 0.560 |
Why?
|
Pulmonary Circulation | 2 | 2012 | 82 | 0.550 |
Why?
|
Ventricular Septum | 1 | 2012 | 13 | 0.550 |
Why?
|
Mass Screening | 1 | 2017 | 574 | 0.550 |
Why?
|
Pulmonary Subvalvular Stenosis | 1 | 2012 | 1 | 0.540 |
Why?
|
United States | 17 | 2020 | 5574 | 0.540 |
Why?
|
Echocardiography | 4 | 2020 | 766 | 0.520 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2012 | 69 | 0.520 |
Why?
|
Systole | 1 | 2012 | 138 | 0.520 |
Why?
|
Aneurysm | 1 | 2012 | 53 | 0.520 |
Why?
|
Image Enhancement | 2 | 2013 | 663 | 0.520 |
Why?
|
Evidence-Based Medicine | 9 | 2019 | 413 | 0.510 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2011 | 6 | 0.510 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 161 | 0.510 |
Why?
|
Smoking | 3 | 2017 | 542 | 0.500 |
Why?
|
Pulmonary Infarction | 1 | 2010 | 1 | 0.480 |
Why?
|
Disease Progression | 5 | 2019 | 1354 | 0.480 |
Why?
|
Immunocompromised Host | 3 | 2019 | 128 | 0.480 |
Why?
|
Hematoma | 1 | 2011 | 77 | 0.480 |
Why?
|
Respiratory Distress Syndrome, Adult | 2 | 2015 | 94 | 0.470 |
Why?
|
Lung Diseases, Fungal | 1 | 2010 | 25 | 0.470 |
Why?
|
Mucormycosis | 1 | 2010 | 15 | 0.460 |
Why?
|
Mitral Valve | 1 | 2012 | 205 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 284 | 0.450 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 307 | 0.450 |
Why?
|
Genomics | 6 | 2021 | 536 | 0.450 |
Why?
|
Amyloidosis | 1 | 2010 | 75 | 0.450 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2009 | 4 | 0.430 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 2280 | 0.430 |
Why?
|
Graft Rejection | 1 | 2016 | 1088 | 0.420 |
Why?
|
Heart Diseases | 1 | 2012 | 297 | 0.420 |
Why?
|
Colorado | 3 | 2019 | 34 | 0.410 |
Why?
|
Asthma | 1 | 2016 | 773 | 0.410 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 184 | 0.410 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 2133 | 0.400 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 271 | 0.400 |
Why?
|
Radiographic Image Enhancement | 4 | 2016 | 530 | 0.390 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2020 | 127 | 0.390 |
Why?
|
Phenotype | 5 | 2019 | 2098 | 0.390 |
Why?
|
Cystectomy | 2 | 2018 | 57 | 0.390 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 113 | 0.380 |
Why?
|
Aorta | 2 | 2020 | 270 | 0.380 |
Why?
|
Heart Defects, Congenital | 2 | 2018 | 323 | 0.370 |
Why?
|
Observer Variation | 3 | 2017 | 746 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2018 | 873 | 0.370 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 92 | 0.370 |
Why?
|
Respiratory Tract Infections | 3 | 2019 | 92 | 0.360 |
Why?
|
Respiratory Tract Diseases | 2 | 2018 | 44 | 0.360 |
Why?
|
Mutation | 4 | 2020 | 3570 | 0.360 |
Why?
|
Abnormalities, Multiple | 1 | 2008 | 237 | 0.360 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2016 | 4 | 0.350 |
Why?
|
Hematologic Neoplasms | 1 | 2009 | 266 | 0.340 |
Why?
|
Multivariate Analysis | 6 | 2018 | 992 | 0.340 |
Why?
|
Liver Neoplasms | 3 | 2017 | 589 | 0.330 |
Why?
|
Arthritis, Rheumatoid | 2 | 2017 | 140 | 0.320 |
Why?
|
Aged, 80 and over | 10 | 2021 | 6136 | 0.320 |
Why?
|
Feasibility Studies | 3 | 2020 | 682 | 0.310 |
Why?
|
Genotype | 3 | 2016 | 1783 | 0.310 |
Why?
|
Algorithms | 7 | 2019 | 1878 | 0.310 |
Why?
|
Stroke | 1 | 2012 | 694 | 0.310 |
Why?
|
Angiography | 3 | 2014 | 195 | 0.290 |
Why?
|
Hypertension, Pulmonary | 3 | 2018 | 311 | 0.290 |
Why?
|
Biological Specimen Banks | 2 | 2020 | 36 | 0.280 |
Why?
|
Carcinoma, Bronchogenic | 2 | 2013 | 31 | 0.280 |
Why?
|
Hemoptysis | 2 | 2014 | 23 | 0.270 |
Why?
|
Serologic Tests | 2 | 2020 | 45 | 0.260 |
Why?
|
Software | 3 | 2018 | 625 | 0.260 |
Why?
|
Pandemics | 3 | 2020 | 335 | 0.260 |
Why?
|
Medical History Taking | 2 | 2020 | 78 | 0.250 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2019 | 36 | 0.250 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 681 | 0.250 |
Why?
|
Neoplasm Staging | 6 | 2019 | 1867 | 0.250 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 248 | 0.250 |
Why?
|
Genetic Variation | 2 | 2019 | 1313 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 1147 | 0.240 |
Why?
|
Atrial Septum | 2 | 2010 | 7 | 0.240 |
Why?
|
Internship and Residency | 1 | 2009 | 809 | 0.240 |
Why?
|
Inhalation Exposure | 1 | 2020 | 21 | 0.230 |
Why?
|
Gastropexy | 1 | 2020 | 1 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2010 | 59 | 0.230 |
Why?
|
Ossification, Heterotopic | 1 | 2020 | 30 | 0.230 |
Why?
|
Bronchiolitis | 3 | 2015 | 4 | 0.230 |
Why?
|
Treatment Outcome | 7 | 2020 | 7300 | 0.230 |
Why?
|
Piperidines | 2 | 2018 | 151 | 0.230 |
Why?
|
Radiation Dosage | 2 | 2019 | 224 | 0.230 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 124 | 0.230 |
Why?
|
Coronavirus | 1 | 2020 | 16 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 2 | 2016 | 650 | 0.220 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 20 | 0.220 |
Why?
|
Gastrostomy | 1 | 2020 | 75 | 0.220 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2019 | 10 | 0.220 |
Why?
|
Survival Rate | 3 | 2019 | 1852 | 0.220 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 46 | 0.220 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 105 | 0.220 |
Why?
|
Urologic Neoplasms | 1 | 2020 | 62 | 0.210 |
Why?
|
Autoimmunity | 2 | 2018 | 159 | 0.210 |
Why?
|
Medicare Part B | 1 | 2019 | 3 | 0.210 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 723 | 0.210 |
Why?
|
Artifacts | 3 | 2019 | 224 | 0.210 |
Why?
|
Hematopoietic System | 1 | 2018 | 14 | 0.210 |
Why?
|
Referral and Consultation | 2 | 2019 | 290 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 17 | 0.210 |
Why?
|
Multidetector Computed Tomography | 2 | 2018 | 54 | 0.210 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2019 | 46 | 0.210 |
Why?
|
Seminoma | 1 | 2018 | 13 | 0.210 |
Why?
|
Mediastinal Neoplasms | 1 | 2019 | 51 | 0.200 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 106 | 0.200 |
Why?
|
Carcinoma, Large Cell | 1 | 2018 | 40 | 0.200 |
Why?
|
Quinazolines | 2 | 2018 | 219 | 0.200 |
Why?
|
Parathyroid Neoplasms | 1 | 2018 | 62 | 0.200 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 44 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 524 | 0.200 |
Why?
|
Carbazoles | 1 | 2018 | 49 | 0.200 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2019 | 62 | 0.200 |
Why?
|
Amygdala | 1 | 2018 | 70 | 0.200 |
Why?
|
Drug Substitution | 1 | 2018 | 24 | 0.200 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 1381 | 0.200 |
Why?
|
Statistics as Topic | 2 | 2017 | 324 | 0.200 |
Why?
|
Lymphocytes | 1 | 2020 | 460 | 0.190 |
Why?
|
Pulmonary Emphysema | 1 | 2017 | 20 | 0.190 |
Why?
|
Occupational Diseases | 2 | 2016 | 53 | 0.190 |
Why?
|
Risk Factors | 6 | 2019 | 4896 | 0.190 |
Why?
|
Vasculitis | 1 | 2017 | 41 | 0.190 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 62 | 0.190 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 26 | 0.190 |
Why?
|
Subcutaneous Fat | 1 | 2017 | 23 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 2200 | 0.190 |
Why?
|
Acetylcysteine | 1 | 2018 | 74 | 0.190 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 74 | 0.190 |
Why?
|
Risk Assessment | 4 | 2020 | 2074 | 0.190 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 48 | 0.190 |
Why?
|
Adiposity | 1 | 2017 | 75 | 0.190 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 29 | 0.180 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 35 | 0.180 |
Why?
|
Registries | 2 | 2017 | 553 | 0.180 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 18 | 0.180 |
Why?
|
Case-Control Studies | 3 | 2018 | 1719 | 0.180 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 236 | 0.180 |
Why?
|
Pathology, Clinical | 1 | 2017 | 35 | 0.180 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2016 | 22 | 0.180 |
Why?
|
Common Variable Immunodeficiency | 1 | 2016 | 4 | 0.180 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2019 | 488 | 0.180 |
Why?
|
Software Validation | 1 | 2016 | 4 | 0.180 |
Why?
|
Prospective Studies | 6 | 2021 | 3554 | 0.170 |
Why?
|
Myositis | 1 | 2016 | 12 | 0.170 |
Why?
|
Mycobacterium avium Complex | 1 | 2016 | 8 | 0.170 |
Why?
|
Hyperlipidemias | 1 | 2017 | 131 | 0.170 |
Why?
|
Azathioprine | 1 | 2016 | 119 | 0.170 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2018 | 817 | 0.170 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 907 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 348 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 398 | 0.170 |
Why?
|
Atmospheric Pressure | 1 | 2015 | 4 | 0.170 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 159 | 0.170 |
Why?
|
Hospitalization | 2 | 2018 | 652 | 0.160 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 216 | 0.160 |
Why?
|
Altitude | 1 | 2015 | 36 | 0.160 |
Why?
|
Neuroendocrine Cells | 1 | 2015 | 2 | 0.160 |
Why?
|
Stress, Psychological | 1 | 2018 | 281 | 0.160 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 186 | 0.160 |
Why?
|
Rib Fractures | 1 | 2014 | 4 | 0.160 |
Why?
|
Cystic Fibrosis | 1 | 2016 | 123 | 0.150 |
Why?
|
Pneumonia, Aspiration | 1 | 2014 | 17 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 344 | 0.150 |
Why?
|
Guideline Adherence | 1 | 2016 | 214 | 0.150 |
Why?
|
Breast Neoplasms | 2 | 2018 | 2567 | 0.150 |
Why?
|
Heterozygote | 1 | 2016 | 360 | 0.150 |
Why?
|
Acute Disease | 4 | 2019 | 822 | 0.150 |
Why?
|
Carrier Proteins | 1 | 2018 | 674 | 0.150 |
Why?
|
Prosthesis Failure | 1 | 2015 | 141 | 0.150 |
Why?
|
Heart Ventricles | 1 | 2020 | 684 | 0.150 |
Why?
|
Cardiac Imaging Techniques | 1 | 2014 | 20 | 0.150 |
Why?
|
Emphysema | 1 | 2014 | 14 | 0.150 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2014 | 6 | 0.150 |
Why?
|
Glass | 1 | 2014 | 15 | 0.150 |
Why?
|
Biopsy, Needle | 2 | 2012 | 266 | 0.150 |
Why?
|
Bronchoscopy | 4 | 2020 | 127 | 0.150 |
Why?
|
Bronchial Diseases | 1 | 2013 | 12 | 0.140 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 1004 | 0.140 |
Why?
|
User-Computer Interface | 2 | 2012 | 178 | 0.140 |
Why?
|
Patient Care Team | 1 | 2016 | 245 | 0.140 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 611 | 0.140 |
Why?
|
Thorax | 1 | 2013 | 52 | 0.140 |
Why?
|
Protons | 1 | 2013 | 90 | 0.140 |
Why?
|
Comorbidity | 1 | 2017 | 844 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2014 | 95 | 0.140 |
Why?
|
Antibodies, Antinuclear | 3 | 2018 | 87 | 0.140 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 529 | 0.140 |
Why?
|
Phantoms, Imaging | 2 | 2014 | 358 | 0.140 |
Why?
|
DiGeorge Syndrome | 1 | 2012 | 11 | 0.140 |
Why?
|
Cleft Palate | 1 | 2012 | 23 | 0.140 |
Why?
|
Mediastinitis | 1 | 2012 | 14 | 0.140 |
Why?
|
Histoplasmosis | 1 | 2012 | 22 | 0.130 |
Why?
|
Pulmonary Diffusing Capacity | 3 | 2017 | 24 | 0.130 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 56 | 0.130 |
Why?
|
Vital Capacity | 3 | 2017 | 53 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 38 | 0.130 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2012 | 21 | 0.130 |
Why?
|
Pericarditis, Constrictive | 1 | 2012 | 5 | 0.130 |
Why?
|
Chicago | 1 | 2017 | 1292 | 0.130 |
Why?
|
Critical Care | 1 | 2015 | 323 | 0.130 |
Why?
|
Cardiac Tamponade | 1 | 2012 | 18 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2011 | 23 | 0.130 |
Why?
|
Atlases as Topic | 1 | 2011 | 7 | 0.130 |
Why?
|
Alleles | 1 | 2016 | 1083 | 0.130 |
Why?
|
Heart Septum | 1 | 2012 | 45 | 0.130 |
Why?
|
Thoracic Diseases | 1 | 2012 | 29 | 0.130 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 84 | 0.120 |
Why?
|
Inflammation | 1 | 2017 | 844 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 1002 | 0.120 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 819 | 0.120 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 1446 | 0.120 |
Why?
|
Tomography, Spiral Computed | 1 | 2011 | 80 | 0.120 |
Why?
|
Bronchiectasis | 1 | 2010 | 12 | 0.120 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 511 | 0.120 |
Why?
|
Mitral Valve Insufficiency | 1 | 2012 | 154 | 0.120 |
Why?
|
Genetic Association Studies | 1 | 2012 | 269 | 0.120 |
Why?
|
Cardiomyopathies | 1 | 2013 | 216 | 0.120 |
Why?
|
Hypotension | 1 | 2010 | 67 | 0.110 |
Why?
|
Protein Kinases | 1 | 2011 | 211 | 0.110 |
Why?
|
African Americans | 1 | 2018 | 1018 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2018 | 1196 | 0.110 |
Why?
|
Adipose Tissue | 1 | 2012 | 231 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2017 | 865 | 0.110 |
Why?
|
Fever | 1 | 2010 | 113 | 0.110 |
Why?
|
Delphi Technique | 3 | 2014 | 54 | 0.110 |
Why?
|
Bacteremia | 1 | 2010 | 105 | 0.110 |
Why?
|
Logistic Models | 3 | 2018 | 1091 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 865 | 0.110 |
Why?
|
Trachea | 1 | 2011 | 304 | 0.110 |
Why?
|
Washington | 1 | 2009 | 39 | 0.110 |
Why?
|
Respiratory Function Tests | 2 | 2019 | 133 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2019 | 3613 | 0.100 |
Why?
|
HIV Infections | 1 | 2016 | 599 | 0.100 |
Why?
|
Professional Competence | 1 | 2009 | 72 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 342 | 0.100 |
Why?
|
Palliative Care | 1 | 2010 | 236 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2010 | 160 | 0.100 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2011 | 531 | 0.090 |
Why?
|
Young Adult | 4 | 2020 | 5341 | 0.090 |
Why?
|
Gene Rearrangement | 2 | 2018 | 157 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 532 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 719 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 518 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 371 | 0.080 |
Why?
|
Neoplasms | 1 | 2019 | 2362 | 0.080 |
Why?
|
Forced Expiratory Volume | 2 | 2015 | 104 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 721 | 0.080 |
Why?
|
Patient Selection | 2 | 2020 | 654 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 815 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 5245 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 1150 | 0.070 |
Why?
|
Iopamidol | 2 | 2013 | 8 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 847 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2019 | 1647 | 0.070 |
Why?
|
ROC Curve | 2 | 2019 | 855 | 0.070 |
Why?
|
Adolescent | 3 | 2020 | 8442 | 0.070 |
Why?
|
Signal Transduction | 3 | 2019 | 3174 | 0.060 |
Why?
|
New York | 1 | 2020 | 58 | 0.060 |
Why?
|
Cryosurgery | 1 | 2020 | 38 | 0.060 |
Why?
|
Ontario | 1 | 2020 | 51 | 0.060 |
Why?
|
Cardiac Output | 1 | 2020 | 147 | 0.060 |
Why?
|
North America | 1 | 2020 | 170 | 0.060 |
Why?
|
Telomerase | 1 | 2019 | 43 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 2064 | 0.050 |
Why?
|
Genetic Markers | 1 | 2021 | 492 | 0.050 |
Why?
|
Genomic Structural Variation | 1 | 2019 | 3 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 57 | 0.050 |
Why?
|
Organ Size | 1 | 2020 | 372 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 2306 | 0.050 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2018 | 9 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2018 | 4 | 0.050 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 7 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2018 | 22 | 0.050 |
Why?
|
Motion | 1 | 2019 | 70 | 0.050 |
Why?
|
Consensus | 1 | 2020 | 235 | 0.050 |
Why?
|
Equipment Design | 1 | 2020 | 405 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 42 | 0.050 |
Why?
|
Italy | 1 | 2018 | 92 | 0.050 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 103 | 0.050 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 36 | 0.050 |
Why?
|
Anilides | 1 | 2018 | 44 | 0.050 |
Why?
|
Mutation Rate | 1 | 2018 | 42 | 0.050 |
Why?
|
Child | 2 | 2019 | 6125 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2020 | 454 | 0.050 |
Why?
|
Odds Ratio | 1 | 2020 | 676 | 0.050 |
Why?
|
Propensity Score | 1 | 2018 | 113 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 132 | 0.050 |
Why?
|
Treatment Failure | 1 | 2018 | 292 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 87 | 0.050 |
Why?
|
Phototherapy | 1 | 2017 | 31 | 0.050 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2019 | 269 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2019 | 169 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 232 | 0.050 |
Why?
|
Rheumatoid Factor | 1 | 2017 | 17 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 165 | 0.050 |
Why?
|
Whole Body Imaging | 1 | 2017 | 36 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 231 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2017 | 143 | 0.050 |
Why?
|
Cause of Death | 1 | 2018 | 261 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2017 | 297 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 421 | 0.050 |
Why?
|
Pneumocystis carinii | 1 | 2016 | 2 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2015 | 1517 | 0.040 |
Why?
|
Hypersplenism | 1 | 2016 | 2 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2017 | 201 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2017 | 171 | 0.040 |
Why?
|
Mice, Nude | 1 | 2018 | 762 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 244 | 0.040 |
Why?
|
Heart Rate | 1 | 2019 | 481 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2016 | 86 | 0.040 |
Why?
|
Risk | 1 | 2018 | 675 | 0.040 |
Why?
|
Leukopenia | 1 | 2016 | 64 | 0.040 |
Why?
|
Pyridines | 1 | 2018 | 287 | 0.040 |
Why?
|
Arthritis | 1 | 2016 | 42 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2017 | 359 | 0.040 |
Why?
|
Anthracosis | 1 | 2016 | 1 | 0.040 |
Why?
|
Silicosis | 1 | 2016 | 2 | 0.040 |
Why?
|
Asbestosis | 1 | 2016 | 5 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 951 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2016 | 52 | 0.040 |
Why?
|
Genome | 1 | 2019 | 326 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2016 | 106 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 347 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 327 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2016 | 354 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 374 | 0.040 |
Why?
|
Neuroblastoma | 1 | 2020 | 441 | 0.040 |
Why?
|
Animals | 2 | 2018 | 25499 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2016 | 430 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2016 | 169 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2018 | 1190 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 254 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2019 | 1088 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 320 | 0.040 |
Why?
|
Physical Examination | 1 | 2016 | 143 | 0.040 |
Why?
|
Lung Abscess | 1 | 2014 | 7 | 0.040 |
Why?
|
Hyperplasia | 1 | 2015 | 153 | 0.040 |
Why?
|
Multiple Trauma | 1 | 2014 | 30 | 0.040 |
Why?
|
Thoracic Wall | 1 | 2014 | 20 | 0.040 |
Why?
|
Diaphragm | 1 | 2014 | 51 | 0.040 |
Why?
|
Pleural Effusion | 1 | 2014 | 46 | 0.040 |
Why?
|
Aortography | 1 | 2014 | 60 | 0.040 |
Why?
|
Lung Injury | 1 | 2014 | 44 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 1192 | 0.040 |
Why?
|
Chest Pain | 1 | 2014 | 40 | 0.040 |
Why?
|
Signal-To-Noise Ratio | 1 | 2014 | 92 | 0.040 |
Why?
|
Foreign Bodies | 1 | 2014 | 55 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 97 | 0.040 |
Why?
|
Tracheal Neoplasms | 1 | 2013 | 7 | 0.040 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2013 | 14 | 0.040 |
Why?
|
Evidence-Based Dentistry | 1 | 2013 | 9 | 0.040 |
Why?
|
Bronchial Neoplasms | 1 | 2013 | 10 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 2056 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 522 | 0.040 |
Why?
|
Protein Conformation | 1 | 2016 | 856 | 0.040 |
Why?
|
Airway Obstruction | 1 | 2014 | 111 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 663 | 0.030 |
Why?
|
Gene Order | 1 | 2012 | 25 | 0.030 |
Why?
|
Inpatients | 1 | 2015 | 209 | 0.030 |
Why?
|
Health Policy | 1 | 2014 | 153 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 430 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 369 | 0.030 |
Why?
|
Collagen Diseases | 1 | 2012 | 3 | 0.030 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2012 | 2 | 0.030 |
Why?
|
Child, Preschool | 1 | 2020 | 3571 | 0.030 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2012 | 22 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2014 | 179 | 0.030 |
Why?
|
Databases, Factual | 1 | 2016 | 752 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2015 | 322 | 0.030 |
Why?
|
Liver | 1 | 2017 | 1185 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2017 | 1773 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 2138 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 184 | 0.030 |
Why?
|
Rare Diseases | 1 | 2012 | 53 | 0.030 |
Why?
|
Diastole | 1 | 2012 | 141 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 1380 | 0.030 |
Why?
|
Area Under Curve | 1 | 2011 | 336 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2012 | 201 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 766 | 0.030 |
Why?
|
Ultrasonography | 1 | 2012 | 656 | 0.030 |
Why?
|
Computer Simulation | 1 | 2014 | 1087 | 0.030 |
Why?
|
Cell Survival | 1 | 2011 | 993 | 0.030 |
Why?
|
Base Sequence | 1 | 2012 | 2390 | 0.020 |
Why?
|
Electrocardiography | 1 | 2010 | 510 | 0.020 |
Why?
|
Mice | 1 | 2018 | 10400 | 0.020 |
Why?
|